NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1720088677 MD
Verify on CMS → Carlos Marchini, MD
Pulmonary Disease Physician in Grants Pass, Oregon.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 313 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81/100
▼ 3 pts below national avg 83.5 · Above neutral
Industry payments
$795.16
10 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Carlos Marchini, MD reported a CMS MIPS final score of 81/100 - below the 83.5 national average - and filed 2,300 Medicare Part D claims in 2024.
- 81/100
- MIPS score · -3 vs avg
- 2K
- Part D claims, 2024
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Carlos Marchini, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720088677), first enumerated 07/21/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,300 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 81/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$795.16 in reported industry payments (10 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720088677 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1720088677
- ENUM-LEGACY 2005
- TAX-MID 10K Pulmonary Disease
- MIPS-INLINE 81/100
- RX-MID 2,300
- BOOK-THIN 114 in Oregon
- PHOTO-FINISH Abdulgadir Adam · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Marchini · this …
Marchini · this provider
81 MIPS pts
- Muhammad Alam · …
Muhammad Alam
81 MIPS pts
- Kevin Chong · near
Kevin Chong
81 MIPS pts
- David Murphy · n…
David Murphy
81 MIPS pts
- Abdulgadir Adam …
Abdulgadir Adam
81 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Carlos Marchini, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
81 ≥ 30th percentile 30% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Carlos Marchini, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Carlos Marchini, MD writes more Part D claims than 76% of them and scores higher on MIPS quality than 35% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Carlos Marchini, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Carlos Marchini, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Carlos Marchini, MD?
Near national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
2,300 54% vs specialty avg
MIPS final score
81/100 2.5 pts vs avg
Specialty distribution in Oregon
How Pulmonary Disease Physician compares to other specialties among Oregon providers
Medicare quality performance, MIPS
Carlos Marchini, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 81/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720088677 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/21/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
80.9693
Final Score
Measured-score avg: 83.5
62.1595
Quality
84.355
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Carlos Marchini, MD. Source: openpaymentsdata.cms.gov.
Total received
$795
Largest payer
Bayer Healthcare Pharmaceuticals Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Carlos Marchini, MD - brand share 52.0%
Pulmonary Disease Physician average
52% brand-name claims vs 48% generic, on 2,300 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,300
Total Claims
$743K
Total Drug Cost
313
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,985.967
- Total Day Supply
- 79,182
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $719K
- Generic Drug Cost
- $24K
- Antibiotic Claims
- 199
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 60, 65-74: 121, 75-84: 105, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Carlos Marchini, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
503 claims
- Prednisone
Prednisone
219 claims
- Anoro Ellipta 141
Anoro Ellipta
141 claims
- Azithromycin 129
Azithromycin
129 claims
- Trelegy Ellipta 111
Trelegy Ellipta
111 claims
- Spiriva Respimat 82
Spiriva Respimat
82 claims
- Montelukast Sodium 71
Montelukast Sodium
71 claims
- Arnuity Ellipta 65
Arnuity Ellipta
65 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 503 |
| Prednisone | 219 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 141 |
| Azithromycin | 129 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 111 |
| Spiriva Respimat Tiotropium Bromide | 82 |
| Montelukast Sodium | 71 |
| Arnuity Ellipta Fluticasone Furoate | 65 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 63 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 60 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Carlos Marchini, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Carlos Marchini, MD's 2,300 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Marchini, both outside Oregon so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (81 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Oregon
Other clinicians with the same primary specialty enrolled in Oregon, drawn from the same CMS NPPES roster as Marchini.
One of 114 Pulmonary Disease Physician providers enrolled in Oregon, 5 are shown here.
Rishi Arora
Medford, OR
Dr. Kamaljit Atwal
DO
Portland, OR
Dr. Berta Baldovino Navarro
MD
Medford, OR
Dr. Rick Balestra
M.D.
Portland, OR
Dr. Ryan Best
M.D.
Beaverton, OR
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Carlos Marchini, MD's specialty? ▼
Carlos Marchini, MD specializes in Pulmonary Disease Physician and practices in Grants Pass, Oregon. Credentials: MD.
How much does Carlos Marchini, MD prescribe under Medicare Part D? ▼
In 2024, Carlos Marchini, MD wrote 2,300 Medicare Part D claims totaling $743K in drug costs for 313 beneficiaries.
What is Carlos Marchini, MD's Medicare quality score? ▼
Carlos Marchini, MD has a CMS MIPS Final Score of 81/100 (Quality: 62.2, Cost: 84.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Carlos Marchini, MD located? ▼
Carlos Marchini, MD is located at 874 NE 7TH ST, Grants Pass, OR, 97526. Phone: (541) 471-6026.
What is Carlos Marchini, MD's NPI number? ▼
Carlos Marchini, MD's National Provider Identifier (NPI) is 1720088677, issued on 07/21/2005.
Does Carlos Marchini, MD prescribe more brand-name or generic drugs? ▼
Carlos Marchini, MD's prescribing is 52% brand-name and 48% generic drugs by claim count, with $719K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Carlos Marchini, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Carlos Marchini, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Prednisone, Anoro Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Carlos Marchini, MD accept Medicare? ▼
Carlos Marchini, MD appears in CMS Medicare data with 2,300 Part D claims and 313 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Carlos Marchini, MD's credentials? ▼
Carlos Marchini, MD's NPI is 1720088677 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.